As the world aspires to return to normal life after more than a year of surviving the epidemic, countries are scrambling to deliver a vaccine that should be slowly – and hopefully – spreading Coronavirus.
Successfully doing this will depend on the goal of ensuring that millions of doses are produced and shipped. Rich countries are not exclusive The world’s supply of vaccines, and, importantly, actually found doses in human weapons.
The charts and maps below will be updated to show the most up-to-date information on the largest vaccination rollout in history in the United States and around the world.
There are significant differences from state to state in how people are being vaccinated.
The first two vaccines Approved For Emergency use In the United States, developed by the agency Pfizer / Bioentech And Modern, Designed to give two doses at intervals of a few weeks. The Johnson and Johnson Only one dose is required for vaccines approved for use in late February. So vaccinating everyone in the United States ultimately means giving 100 to 200 doses per 100 people across each state and region – or a total of 330 million to 660 million doses for the entire nation. It’s one Huge logistic challenge.
The U.S. vaccine rollout began more slowly than expected. The Trump administration set a goal to give 20 million vaccines Towards the end of 2020. This goal was not reached by the end of January. In early March, President Joe Biden said the United States would have enough vaccines for all adults. At the end of May – His administration had planned two months ago. Nevertheless, there are concerns that the vaccination campaign continues to be poor People And Caste communities Back
Search or navigate through this table to find out what your state or region is doing with these key steps in the vaccine rollout.
Vaccine rollout timeline
The chart shows the number of vaccines given per 100 people for each state since the beginning of 2021, outlining the top three states and US national numbers. Type the name of another state or territory in the search bar and select Add Author.
This chart shows the daily number of vaccine doses given across the country since 2021. Due to a spike in data due to lagging behind in reporting, the average day-to-day average rotating line of day-to-day doses gives a clear idea of whether the rollout is accelerating or slowing down.
Vaccine rollout by country
This map shows the dosage of vaccines given to more than 100 people in more countries as these numbers are more widely published.
America is ahead of most other countries in vaccine rollout. But among the great nations was Israel Early leader.
Search or navigate this table to see what each race is doing. It reveals that some nations have adopted different strategies: for example, the UK has decided to give as many people as possible the initial dose, delaying their second shot.
Vaccine rollout timeline
This chart shows the number of vaccines given to every 100 people for each country since the beginning of 2021. Type the name of any nation in any search bar and select to compare its timeline with the United States and the top three countries leading the global vaccine rollout. Only countries that have started their vaccination campaigns will attend.
This chart shows the daily number of vaccine doses given to people worldwide. Due to the spikes in the reporting lag, the ses day rolling average dose given line gives a clear idea of whether the rollout is accelerating or slowing down.
Status of leading vaccines
This table documents the status of the top COVID-19 vaccines for use in the United States and other sold-out markets, advertisements for approval, and pricing from purchase agreement information. Compiled by UNICEF, Where available.
Pfizer / Bioentech and Moderner vaccines, including clinical trial results that indicate More 90% effective Disease prevention, based on a New technology It provides a sequence of RNAs that make our own cells viral proteins, triggering an immune response.
The downside is that these vaccines are more expensive than the cost of spreading genetic material from the coronavirus to a disabled version of another virus, such as those produced by the Anglo-Swedish company AstraZeneca, Based on research from Oxford University, Johnson and Johnson, And Russia Gamalia Research Institute.
Other leading vaccines are made based on inactivated versions of the coronavirus, the long-term method of making the vaccine, or protein subunits from the virus.
Jeremy Singer-Vine contributed reporting for this story.